Relationship Between Nonsustained Ventricular Tachycardia After Non–ST-Elevation Acute Coronary Syndrome and Sudden Cardiac Death: Observations From the Metabolic Efficiency With Ranolazine for Less Ischemia in Non–ST-Elevation Acute Coronary Syndrome–Thrombolysis in Myocardial Infarction 36 (MERLIN
暂无分享,去创建一个
David A. Morrow | Benjamin M. Scirica | Jindrich Spinar | E. Braunwald | D. Morrow | B. Scirica | F. Verheugt | J. Qin | L. Belardinelli | E. Karwatowska-Prokopczuk | Eugene Braunwald | Luiz Belardinelli | J. Špinar | Whedy Wang | Jie Qin | Chester M. Hedgepeth | Ewa Karwatowska-Prokopczuk | Freek W. A. Verheugt | Whedy Wang | C. Hedgepeth
[1] A. Skene,et al. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial. , 2007, JAMA.
[2] Pekka Raatikainen,et al. Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. , 2003, Journal of the American College of Cardiology.
[3] L. Wallentin,et al. Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study. , 2004, Clinical chemistry.
[4] M. Pencina,et al. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.
[5] R. Califf,et al. Sustained Ventricular Arrhythmias Among Patients With Acute Coronary Syndromes With No ST-Segment Elevation: Incidence, Predictors, and Outcomes , 2002, Circulation.
[6] S. Hohnloser,et al. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era. , 1999, Journal of the American College of Cardiology.
[7] R. Califf,et al. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease. , 2005, JAMA.
[8] J. Shryock,et al. An increase of late sodium current induces delayed afterdepolarizations and sustained triggered activity in atrial myocytes. , 2008, American journal of physiology. Heart and circulatory physiology.
[9] Barry J Maron,et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. A scientific statement from the American Heart Association Council on Clinical Cardi , 2008, Journal of the American College of Cardiology.
[10] J. Manson,et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. , 2002, The New England journal of medicine.
[11] P. Armstrong,et al. Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. , 2009, JAMA.
[12] S. Solomon,et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. , 2005, The New England journal of medicine.
[13] A. Skene,et al. Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial. , 2006, American heart journal.
[14] J. Shryock,et al. Antagonism by Ranolazine of the Pro-Arrhythmic Effects of Increasing Late INa in Guinea Pig Ventricular Myocytes , 2004, Journal of cardiovascular pharmacology.
[15] A. Habets,et al. Defibrillator implantation early after myocardial infarction. , 2009, The New England journal of medicine.
[16] Eric Fain,et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. , 2004, The New England journal of medicine.
[17] L. Tavazzi,et al. Prevalence and Prognostic Significance of Ventricular Arrhythmias After Acute Myocardial Infarction in the Fibrinolytic Era GISSI‐2 Results , 1993, Circulation.
[18] Andrew C. Zygmunt,et al. Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic Properties , 2004, Circulation.
[19] Demosthenes G Katritsis,et al. Nonsustained ventricular tachycardia: where do we stand? , 2004, European heart journal.
[20] R. Passman,et al. Implantable cardioverter-defibrillator therapy after acute myocardial infarction: the results are not shocking. , 2009, Journal of the American College of Cardiology.
[21] H. Huikuri,et al. Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era. , 2005, European heart journal.
[22] L E Hinkle,et al. Clinical Classification of Cardiac Deaths , 1982, Circulation.
[23] K. Patton. The riddle of nonsustained ventricular tachycardia and sudden cardiac death: are we approaching a solution? , 2010, Circulation.
[24] A. Camm,et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT , 1997, The Lancet.
[25] A. Kadish,et al. Nonsustained ventricular tachycardia in the setting of acute myocardial infarction: tachycardia characteristics and their prognostic implications. , 1998, Circulation.
[26] A J Camm,et al. Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials , 2001, Circulation.
[27] J. Fleiss,et al. Prevalence, characteristics and significance of ventricular tachycardia detected by 24-hour continuous electrocardiographic recordings in the late hospital phase of acute myocardial infarction. , 1986, The American journal of cardiology.
[28] M. Pfisterer,et al. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS) , 1990, Journal of the American College of Cardiology.
[29] S. Solomon,et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. , 2005, The New England journal of medicine.
[30] Dan M. Roden,et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines , 2006 .